Merck & Co.
Tracked across 12 events · 486 articles · First seen Jan 28, 2026 · Last active Mar 28, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
NewsDesk Dashboard
Tech
Merck & Co. funded the study for enlicitide, a new pill that significantly reduces LDL cholesterol. This drug, if approved by the United States===Food and Drug Administration, could be a major new product for Merck & Co., potentially offering an easier-to-use option for millions of people at high risk of heart attacks.
Feb 04, 2026 · 24 articles
Regulatory
Merck & Co., the manufacturer of Merck & Co.===Gardasil, will see increased demand for its vaccine due to India's nationwide vaccination program, potentially boosting its revenue and market share in the region.
Feb 24, 2026 · 103 articles
Business
Anton Groom, Chief AI Officer at Merck & Co., will be a speaker at BioAsia 2026, contributing to discussions on AI in healthcare.
Feb 05, 2026 · 7 articles
Business
Merck & Co. rose 2.2% after its quarterly results, showing positive investor reception despite general healthcare sector pressure.
Jan 28, 2026 · 214 articles
Business
Merck & Company Inc (NYSE:MRK) added 2.58% to its stock price, contributing to the Dow's gains.
Feb 17, 2026 · 8 articles
+ 7 more events
View on Dashboard
NEWSDESK
Track Merck & Co. live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard